Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot And Ankle Surgeon Training Program
Portfolio Pulse from Benzinga Newsdesk
Paragon 28, Inc. (NYSE:FNA) has announced the expansion of its mobile lab training program with the addition of a second mobile medical education lab. This expansion will enhance the company's ability to provide on-site training and education to foot and ankle surgeons. The new 40-foot lab can accommodate up to 25 surgeons and is equipped with a 5 station cadaveric training facility. Over 70 training sessions are planned across approximately 65 US cities in Q4 2023. Since its launch in July 2022, the program has trained over 350 surgeons and has been integral in showcasing Paragon 28's product portfolio in forefoot, HAV, and hindfoot market segments.
November 13, 2023 | 10:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Paragon 28's addition of a second mobile medical education lab is likely to enhance its training capabilities and market reach for its foot and ankle products, potentially leading to increased adoption and sales.
The expansion of Paragon 28's mobile lab program is directly related to the company's efforts to educate surgeons on its products, which is a critical step in driving product adoption. The success of the initial program and the planned increase in training sessions suggest a positive outlook for the company's growth in the foot and ankle market segments. This strategic move is likely to be viewed favorably by investors, as it demonstrates the company's commitment to growth and innovation in medical education.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100